-
Following Extended Consolidation Period, Biotech ETF's Next Breakout Could Be Big
Friday, June 16, 2017 - 9:57am | 371After some huge swings in the past three years, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) has been relatively quiet for the past few months, trading mostly sideways within a very narrow range. The extended consolidation period may mean the IBB’s next breakout will be a big...
-
Assessing The Legitimacy Of The Biotech ETF Bounce
Friday, November 18, 2016 - 12:56pm | 501Putting personal politics aside for a moment, it is not unreasonable to assume that investors who were long biotechnology stocks and exchange-traded funds into Election Day are happy with the outcome. Leading up to Election Day, Democratic nominee Hillary Clinton and her harsh rhetoric against high...
-
Biotech Rally Stokes Activity In Leveraged ETFs
Thursday, August 4, 2016 - 1:46pm | 571About a year after reaching all-time highs, biotechnology exchange-traded funds are rallying after starting 2016 on dismal notes. Over the past month, the three largest U.S. biotechnology ETFs are up an average of almost 15 percent. LABU And LABD Predictably, the recent biotech rally is...
-
This Biotech ETF Could Be Ready To Party
Friday, May 27, 2016 - 1:11pm | 525In what has been a trying year for biotechnology stocks and exchange-traded funds, traders and investors are likely tired of hearing about when this group is finally going to deliver some legitimate upside. Although the popular triple-leveraged biotech ETF Direxion Daily S&P Biotech Bull 3X...
-
Rebound For Big Biotech ETF Will Require Some Patience
Tuesday, February 9, 2016 - 9:05am | 570On Monday, more than 120 exchange traded funds hit 52-week lows and nearly 10 of those funds were biotechnology ETFs. That group included the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB), the largest biotechnology ETF by assets. IBB finished lower by nearly 3.2 percent yesterday....
-
Traders Get Adventurous With Leveraged Biotech ETFs
Wednesday, October 28, 2015 - 3:12pm | 671After a third-quarter swoon that saw the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) and the SPDR S&P Biotech (ETF) (NYSE: XBI), two of the largest biotech exchange-traded funds by assets, tumble 18.1 percent and 24.4 percent, respectively, traders have displayed caution regarding...
-
The Best (And Worst) ETFs Of Last Week Amid Social Media's Collapse
Sunday, May 3, 2015 - 6:09pm | 488The rug was unceremoniously pulled out from under the bulls this past week as several key earnings misses and economic data surprises led to a muted decline in stocks. The SPDR S&P 500 ETF Trust (NYSE: SPY) jostled lower for much of the week and continues to underscore the difficulty...
-
RTI Biologics and STAAR Surgical End the Week Near 52-Week Highs
Saturday, August 20, 2011 - 11:37am | 541The markets ended the week closing lower two days in a row. Yet small cap biotech companies RTI Biologics (NASDAQ: RTIX) and STAAR Surgical (NASDAQ: STAA) rose to new 52-week highs of $3.75 and $7.08 per share, respectively, in Friday's trading session. RTI Biologics has been in a very strong...